This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Amorepacific Corporation. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Sa-Yong Hong: Innovator in Pharmaceutical Chemistry
Introduction
Sa-Yong Hong is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic effects on inflammatory and immunological disorders.
Latest Patents
Sa-Yong Hong holds a patent for "2-cyclopenten-1-one oxime derivatives inhibiting production of TNF-α." This patent describes the use of 2-cyclopenten-1-one oxime derivatives, represented by Formula (I), or their pharmaceutically acceptable salts, which inhibit the production of TNF-α or PDE4. These compounds show potential therapeutic effects in treating disorders mediated through TNF-α or PDE4. He has 1 patent to his name.
Career Highlights
Sa-Yong Hong is currently employed at Amorepacific Corporation, a leading company in the beauty and cosmetics industry. His work focuses on innovative solutions that enhance health and wellness through advanced pharmaceutical applications.
Collaborations
He collaborates with talented colleagues, including Yeonjoon Kim and Sun-Young Kim, to further advance research and development in their field.
Conclusion
Sa-Yong Hong's contributions to pharmaceutical chemistry and his innovative patent work highlight his role as a key figure in the industry. His ongoing research continues to pave the way for new therapeutic options in treating inflammatory and immunological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile